Cargando…

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis

Tuberculosis (TB), an infection caused by Mycobacterium tuberculosis (Mtb), is one of the primary causes of death globally. The treatment of TB is long and based on several drugs, producing problems in compliance and toxicity, increasing Mtb resistance to first-line antibiotics that result in multid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mata-Espinosa, Dulce, Lara-Espinosa, Jacqueline V., Barrios-Payán, Jorge, Hernández-Pando, Rogelio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610538/ https://www.ncbi.nlm.nih.gov/pubmed/37895946 http://dx.doi.org/10.3390/ph16101475

Ejemplares similares

The Therapeutic Effect of Intranasal Administration of Dexamethasone in Neuroinflammation Induced by Experimental Pulmonary Tuberculosis
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2021)

In Vitro, In Vivo and In Silico Assessment of the Antimicrobial and Immunomodulatory Effects of a Water Buffalo Cathelicidin (WBCATH) in Experimental Pulmonary Tuberculosis
por: Palacios, Jacqueline Barrios, et al.
Publicado: (2022)

Effect of Low Doses of Dexamethasone on Experimental Pulmonary Tuberculosis
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2023)

Involvement of Vasopressin in the Pathogenesis of Pulmonary Tuberculosis: A New Therapeutic Target?
por: Zetter, Mario, et al.
Publicado: (2019)

A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies
por: Rodríguez-Flores, Edén M., et al.
Publicado: (2019)

The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)

Correction: The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)

Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2022)

Beneficial or detrimental activity of regulatory T cells, indoleamine 2,3-dioxygenase, and heme oxygenase-1 in the lungs is influenced by the level of virulence of Mycobacterium tuberculosis strain infection
por: Lozano-Ordaz, Vasti, et al.
Publicado: (2023)

The ctpF Gene Encoding a Calcium P-Type ATPase of the Plasma Membrane Contributes to Full Virulence of Mycobacterium tuberculosis
por: Maya-Hoyos, Milena, et al.
Publicado: (2022)

Experimental Pulmonary Tuberculosis in the Absence of Detectable Brain Infection Induces Neuroinflammation and Behavioural Abnormalities in Male BALB/c Mice
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2020)

The Influence of Sex Steroid Hormones in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Bini, Estela Isabel, et al.
Publicado: (2014)

The Cholinergic System Contributes to the Immunopathological Progression of Experimental Pulmonary Tuberculosis
por: Islas-Weinstein, Leon, et al.
Publicado: (2021)

Structural homology between 11 beta-hydroxysteroid dehydrogenase and Mycobacterium tuberculosis Inh-A enzyme: Dehydroepiandrosterone as a potential co-adjuvant treatment in diabetes-tuberculosis comorbidity
por: Hernández-Bustamante, Israel, et al.
Publicado: (2023)

Antimicrobial Peptide against Mycobacterium Tuberculosis That Activates Autophagy Is an Effective Treatment for Tuberculosis
por: Peláez Coyotl, Erika A., et al.
Publicado: (2020)

Targeted RNA-Seq Reveals the M. tuberculosis Transcriptome from an In Vivo Infection Model
por: Cornejo-Granados, Fernanda, et al.
Publicado: (2021)

Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by Mycobacterium tuberculosis
por: Zatarain-Barrón, Zyanya Lucia, et al.
Publicado: (2020)

BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines
por: Segura-Cerda, Cristian Alfredo, et al.
Publicado: (2020)

Author Correction: BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines
por: Segura-Cerda, Cristian Alfredo, et al.
Publicado: (2020)

Close Related Drug-Resistance Beijing Isolates of Mycobacterium tuberculosis Reveal a Different Transcriptomic Signature in a Murine Disease Progression Model
por: Cerezo-Cortés, María Irene, et al.
Publicado: (2022)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)

Extracellular vesicles released by J774A.1 macrophages reduce the bacterial load in macrophages and in an experimental mouse model of tuberculosis
por: García-Martínez, Mariano, et al.
Publicado: (2019)

Profiling the immune response to Mycobacterium tuberculosis Beijing family infection: a perspective from the transcriptome
por: María Irene, Cerezo-Cortés, et al.
Publicado: (2021)

Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment
por: Jiménez-Arellanes, Adelina, et al.
Publicado: (2013)

Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis
por: Tirado, Yanely, et al.
Publicado: (2015)

Protective Effect of a Lipid-Based Preparation from Mycobacterium smegmatis in a Murine Model of Progressive Pulmonary Tuberculosis
por: García, Maria de los Angeles, et al.
Publicado: (2014)

Detection of Mycobacterial DNA in Human Bone Marrow
por: González-Escalada, Alba, et al.
Publicado: (2023)

Is Adipose Tissue a Place for Mycobacterium tuberculosis Persistence?
por: Neyrolles, Olivier, et al.
Publicado: (2006)

Induction of bone formation in abdominal implants constituted by collagen sponges embedded with plant-based human transforming growth factor family proteins in ectopic dog model
por: Jacinto-Tinajero, Juan Carlos, et al.
Publicado: (2014)

Trypanosoma cruzi High Mobility Group B (TcHMGB) can act as an inflammatory mediator on mammalian cells
por: Cribb, Pamela, et al.
Publicado: (2017)

In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis
por: Martinez-Olivares, Constanza Estefania, et al.
Publicado: (2023)

Viral Vectors in Gene Therapy
por: Lundstrom, Kenneth
Publicado: (2018)

Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis
por: Estrada García, Iris, et al.
Publicado: (2021)

Transcription of Genes Involved in Sulfolipid and Polyacyltrehalose Biosynthesis of Mycobacterium tuberculosis in Experimental Latent Tuberculosis Infection
por: Rodríguez, Jimmy E., et al.
Publicado: (2013)

Mycobacterium tuberculosis Infection Induces BCSFB Disruption but No BBB Disruption In Vivo: Implications in the Pathophysiology of Tuberculous Meningitis
por: Sánchez-Garibay, Carlos, et al.
Publicado: (2022)

Viral Vector-Based Gene Therapy
por: Li, Xuedan, et al.
Publicado: (2023)

Viral vector vaccines
por: McCann, Naina, et al.
Publicado: (2022)

The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges
por: Barrera-Rosales, Alejandra, et al.
Publicado: (2023)

Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches
por: Aledo-Serrano, Angel, et al.
Publicado: (2021)

Development of Viral Vectors for Use in Cardiovascular Gene Therapy
por: Williams, Paul D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_db524p1mj7mn07p1uqnhc3oq0r